Isomorphic Labs
4 stories
-
techIsomorphic Labs Raises $2.1B for AI Drug Discovery Platform
Backed by Alphabet and sovereign wealth funds, the company advances AlphaFold-based drug design toward clinical trials.
-
healthIsomorphic Labs Raises $2.1B to Scale AI Drug Discovery
Google-backed Isomorphic Labs secures $2.1 billion in Series C funding to scale its AI-powered drug design engine and accelerate clinical trials.
-
techAlphabet's Isomorphic Labs Reportedly Raising $2B+ for Medical AI
Isomorphic Labs, an Alphabet unit using AI for drug development, is in talks to raise over $2 billion in funding.
-
techZuckerberg's Biohub Aims to Cure All Disease with AI Cell Models
Mark Zuckerberg and Priscilla Chan's Biohub launches $500M initiative to create AI models of human cells, aiming to accelerate disease prevention and treatment.